Condition: Asthma
Interventions: Biological: Mepolizumab 100mg; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Inverseon Focuses on Mucous and Smoking Cessation – MarketWatch (press release)
|
Inverseon Focuses on Mucous and Smoking Cessation
MarketWatch (press release) 12, 2012 /PRNewswire via COMTEX/ — Inverseon, Inc., a pharmaceutical company developing drug therapies for the treatment of pulmonary disorders, announced that while it anticipates that its asthma program will advance with non-dilutive grants, … |
View full post on asthma – Google News